BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12702553)

  • 1. Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma.
    Svensson S; Nilsson K; Ringberg A; Landberg G
    Cancer Res; 2003 Apr; 63(8):1737-42. PubMed ID: 12702553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
    Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
    Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior.
    Nilsson K; Svensson S; Landberg G
    Mod Pathol; 2004 Dec; 17(12):1464-74. PubMed ID: 15257310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
    Park HW; Song SY; Lee TJ; Jeong D; Lee TY
    Oncol Rep; 2007 Jul; 18(1):267-72. PubMed ID: 17549378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 gene expression in basal cell carcinoma.
    Eshkoor SA; Ismail P; Rahman SA; Oshkour SA
    Arch Med Res; 2008 Oct; 39(7):668-73. PubMed ID: 18760195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
    Enomoto K; Mimura T; Harris DL; Joyce NC
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4330-40. PubMed ID: 17003423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
    Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
    J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence.
    Takahashi A; Ohtani N; Yamakoshi K; Iida S; Tahara H; Nakayama K; Nakayama KI; Ide T; Saya H; Hara E
    Nat Cell Biol; 2006 Nov; 8(11):1291-7. PubMed ID: 17028578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
    Suzuki H; Sugimura H; Hashimoto K
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
    Gizard F; Amant C; Barbier O; Bellosta S; Robillard R; Percevault F; Sevestre H; Krimpenfort P; Corsini A; Rochette J; Glineur C; Fruchart JC; Torpier G; Staels B
    J Clin Invest; 2005 Nov; 115(11):3228-38. PubMed ID: 16239970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.
    Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM; Hoffman HT; Robinson RA
    J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma.
    Liu T; Zhu E; Wang L; Okada T; Yamaguchi A; Okada N
    Hum Pathol; 2005 Sep; 36(9):962-70. PubMed ID: 16153458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters.
    Palmqvist R; Rutegârd JN; Bozoky B; Landberg G; Stenling R
    Am J Pathol; 2000 Dec; 157(6):1947-53. PubMed ID: 11106567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
    Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis.
    Tort F; Bartkova J; Sehested M; Orntoft T; Lukas J; Bartek J
    Cancer Res; 2006 Nov; 66(21):10258-63. PubMed ID: 17079443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.